ABVC BIOPHARMA, INC. - 8-K Filing
ABVC BioPharma enters $4.1M senior convertible note private placement and settles outstanding litigation with Lind Global Fund II. (Items: 1.01 Entry into a Material Definitive Agreement Private Placement of Senior Convertible Promissory Notes On October 30, 2026 (the “Closing Date”), 1.02 Termination of a Material Definitive Agreement The information set forth in Item 1, 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant The information set forth i, 3.02 Unregistered Sales of Equity Securities The information set forth in Item 1)
Tickers: $ABVC
Read the full article at SEC EDGAR
Part of the story Techlott Inc. - 8-K Filing (4 articles)